CHIEF MEDICAL OFFICER
Thu, Jan 2, 2025
Jan 2
exercised or converted securities in ACLX
13,021 shares @ $0.00
Decreased holdings by -33.30%
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
ACLXArcellx, Inc.
Health CareBiotechnology